Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis.
about
Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients.Long-term outcomes of nonpalpable prostate cancer (T1c) patients treated with radical prostatectomy.Aberrant methylation of protocadherin 17 and its clinical significance in patients with prostate cancer after radical prostatectomy
P2860
Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis.
@ast
Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis.
@en
type
label
Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis.
@ast
Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis.
@en
prefLabel
Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis.
@ast
Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis.
@en
P2093
P1433
P1476
Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis.
@en
P2093
Arthur Y Hung
Deborah A Kuban
Larry Levy
P304
P356
10.1097/00130404-200211000-00007
P577
2002-11-01T00:00:00Z